KOD
Price
$7.49
Change
+$0.32 (+4.46%)
Updated
Jan 21, 04:07 PM (EDT)
Capitalization
377.31M
65 days until earnings call
VRDN
Price
$18.60
Change
+$0.47 (+2.59%)
Updated
Jan 21, 04:21 PM (EDT)
Capitalization
1.44B
36 days until earnings call
Ad is loading...

KOD vs VRDN

Header iconKOD vs VRDN Comparison
Open Charts KOD vs VRDNBanner chart's image
Kodiak Sciences
Price$7.49
Change+$0.32 (+4.46%)
Volume$3.04K
Capitalization377.31M
Viridian Therapeutics
Price$18.60
Change+$0.47 (+2.59%)
Volume$300
Capitalization1.44B
KOD vs VRDN Comparison Chart
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. VRDN commentary
Jan 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Hold and VRDN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 21, 2025
Stock price -- (KOD: $7.17 vs. VRDN: $18.13)
Brand notoriety: KOD and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 63% vs. VRDN: 78%
Market capitalization -- KOD: $377.31M vs. VRDN: $1.44B
KOD [@Biotechnology] is valued at $377.31M. VRDN’s [@Biotechnology] market capitalization is $1.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $351.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, KOD is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 2 TA indicator(s) are bullish while VRDN’s TA Score has 1 bullish TA indicator(s).

  • KOD’s TA Score: 2 bullish, 5 bearish.
  • VRDN’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, VRDN is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а -13.82% price change this week, while VRDN (@Biotechnology) price change was -0.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.37%. For the same industry, the average monthly price growth was +2.13%, and the average quarterly price growth was -0.58%.

Reported Earning Dates

KOD is expected to report earnings on May 14, 2025.

VRDN is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+1.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.44B) has a higher market cap than KOD($377M). VRDN YTD gains are higher at: -5.425 vs. KOD (-27.940). KOD has higher annual earnings (EBITDA): -164.93M vs. VRDN (-253.41M). VRDN has more cash in the bank: 753M vs. KOD (198M). VRDN has less debt than KOD: VRDN (21.1M) vs KOD (73.4M). VRDN has higher revenues than KOD: VRDN (302K) vs KOD (0).
KODVRDNKOD / VRDN
Capitalization377M1.44B26%
EBITDA-164.93M-253.41M65%
Gain YTD-27.940-5.425515%
P/E RatioN/AN/A-
Revenue0302K-
Total Cash198M753M26%
Total Debt73.4M21.1M348%
FUNDAMENTALS RATINGS
KOD vs VRDN: Fundamental Ratings
KOD
VRDN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
10059
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3560
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (32) in the Biotechnology industry is somewhat better than the same rating for VRDN (92). This means that KOD’s stock grew somewhat faster than VRDN’s over the last 12 months.

VRDN's Profit vs Risk Rating (59) in the Biotechnology industry is somewhat better than the same rating for KOD (100). This means that VRDN’s stock grew somewhat faster than KOD’s over the last 12 months.

VRDN's SMR Rating (98) in the Biotechnology industry is in the same range as KOD (98). This means that VRDN’s stock grew similarly to KOD’s over the last 12 months.

KOD's Price Growth Rating (35) in the Biotechnology industry is in the same range as VRDN (60). This means that KOD’s stock grew similarly to VRDN’s over the last 12 months.

KOD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VRDN (100). This means that KOD’s stock grew similarly to VRDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODVRDN
RSI
ODDS (%)
Bearish Trend 14 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 14 days ago
89%
Bearish Trend 14 days ago
85%
Momentum
ODDS (%)
Bearish Trend 14 days ago
77%
Bearish Trend 14 days ago
85%
MACD
ODDS (%)
Bearish Trend 14 days ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 14 days ago
85%
Bearish Trend 14 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 14 days ago
89%
Bearish Trend 14 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 19 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 14 days ago
84%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGSX24.280.30
+1.25%
Fidelity Series Growth Company
UGTCX27.720.18
+0.65%
Victory Growth and Tax Strategy C
LBGCX38.010.21
+0.56%
ClearBridge Mid Cap Growth C
MMUIX23.050.07
+0.30%
MFS Utilities I
HRMGX5.23N/A
N/A
Harbor Disruptive Innovation Admin

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with IMNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
-6.15%
IMNM - KOD
42%
Loosely correlated
+1.32%
AKBA - KOD
39%
Loosely correlated
+7.25%
RCKT - KOD
39%
Loosely correlated
+0.98%
NUVB - KOD
38%
Loosely correlated
-1.18%
PLRX - KOD
38%
Loosely correlated
-3.36%
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with ALLO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
+6.27%
ALLO - VRDN
51%
Loosely correlated
-1.09%
FATE - VRDN
48%
Loosely correlated
+1.60%
AURA - VRDN
47%
Loosely correlated
+1.30%
ABCL - VRDN
45%
Loosely correlated
+1.02%
CRBU - VRDN
45%
Loosely correlated
-0.65%
More